<?xml version="1.0" ?>
<document id="28290464">
  <sentence id="28290464.s0" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="116-121" id="28290464.s0.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-198" id="28290464.s0.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <entity charOffset="202-212" id="28290464.s0.e2" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="28290464.s0.e0" e2="28290464.s0.e2" id="28290464.s0.p0" relation="true"/>
    <pair e1="28290464.s0.e0" e2="28290464.s0.e1" id="28290464.s0.p1" relation="true"/>
  </sentence>
  <sentence id="28290464.s1" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with phosphatidylinositol biosynthetic process recognition of CCL18 may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="57-62" id="28290464.s1.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-125" id="28290464.s1.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="28290464.s1.e0" e2="28290464.s1.e1" id="28290464.s1.p0" relation="true"/>
  </sentence>
</document>
